France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer’s Disease-Reference-Cited by-同舟云学术

France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer’s Disease

Published:2018-10-30 Issue:2 Volume:66 Page:425-427
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Krolak-Salmon Pierre¹,Dubois Bruno²,Sellal François³,Delabrousse-Mayoux Jean-Philippe⁴,Vandel Pierre⁵,Amieva Hélène⁶,Jeandel Claude⁷,Andrieu Sandrine⁸,Perret-Liaudet Armand¹

Affiliation:

1. Fédération des Centres Mémoire, Lyon, France

2. Société Française de Neurologie, Paris, France

3. Fédération Française de Neurologie, Aix-en-Provence, France

4. Association des Neurologues Libéraux de Langue Française, Bergerac, France

5. Société Francophone de psychogériatrie et de psychiatrie de la personne âgée, Paris, France

6. Société de Neuropsychologie de Langue Française, France

7. Collège National Professionnel de Gériatrie, Suresnes, France

8. Société Française de Gériatrie et de Gérontologie, Paris, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference4 articles.

1. Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia;Tan;Alzheimers Dement,2018

2. Isik AT , Soysal P , Stubbs B , Solmi M , Basso C , Maggi S , Schofield P , Veronese N , Mueller C (2018) Cardiovascular outcomes of cholinesterase inhibitors in individuals with dementia: A meta-analysis and systematic review. J Am Geriatr Soc 66, 1805–1811.

3. Donepezil for dementia due to Alzheimer’s disease;Birks;Cochrane Database Syst Rev,2018

4. Oltra-Cucarella J , Ferrer-Cascales R , Clare L , Morris SB , Espert R , Tirapu J , Sánchez-SanSegundo M (2018) Differential effects of cognition-focused interventions for people with Alzheimer’s disease: A meta-analysis. Neuropsychology 32, 664–679.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Que sait-on de la mémantine comme traitement de la maladie d’Alzheimer en 2024 ?;NPG Neurologie - Psychiatrie - Gériatrie;2024-09

2. The Application of Fully Immersive Virtual Reality on Reminiscence Interventions for Older Adults: Scoping Review (Preprint);2023-01-05

3. Polypharmacy in Older Adults with Alzheimer’s Disease;Medicina;2022-10-13

4. The impacts of health insurance and resource on the burden of Alzheimer's disease and related dementias in the world population;Alzheimer's & Dementia;2022-07-12

5. Pratique de l’annonce du diagnostic de la maladie d’Alzheimer;La Presse Médicale Formation;2022-06